The Oxford Pain, Activity and Lifestyle (OPAL) Cohort Study
NCT02820571 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5409
Last updated 2021-04-29
Summary
The OPAL study is about health outcomes in older adults. The investigators are surveying 4,000 adults across England to see how health and physical activity change over time. The information that is collected will help the investigators to understand how a person's health, including conditions such as back pain, affect their mobility as they age, and provide insight into improving the management of health in older adults.
Conditions
- Low Back Pain
Sponsors & Collaborators
-
University of Oxford
lead OTHER
Principal Investigators
-
Sarah Lamb · University of Oxford
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-04
- Primary Completion
- 2023-03-31
- Completion
- 2023-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
NCT00449176 ·Status: COMPLETED ·Phase: PHASE3
-
Tapentadol Versus Oxycodone - a Mechanism-based Treatment Approach in Neuropathic Pain
NCT01458015 ·Status: TERMINATED ·Phase: PHASE4
-
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
NCT01177280 ·Status: COMPLETED
-
A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers
NCT01530542 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain
NCT02716857 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers
NCT01677065 ·Status: COMPLETED
-
Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.
NCT01838616 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers
NCT01552863 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
NCT00361504 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions
NCT02089295 ·Status: COMPLETED ·Phase: PHASE1
-
A Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers
NCT01568450 ·Status: COMPLETED ·Phase: PHASE1
-
NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain
NCT00986180 ·Status: COMPLETED ·Phase: PHASE3
-
Patient-Centered Opioid Tapering Study
NCT03303209 ·Status: COMPLETED
-
A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers
NCT01779492 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Trial Comparing Oxycodone Medications
NCT01162304 ·Status: TERMINATED ·Phase: PHASE4
-
Opioid Taper Study
NCT03912298 ·Status: COMPLETED
-
Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions
NCT02059915 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Chronic Pain Self-Management in Clinic or Community for Low-Income Hispanics
NCT02906358 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation
NCT01677039 ·Status: COMPLETED ·Phase: PHASE1
-
Evolution of Analgesic Tolerance With Opioids
NCT00275249 ·Status: COMPLETED ·Phase: NA
-
Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)
NCT01545778 ·Status: COMPLETED
-
To Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
NCT01101178 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Chronic Low Back Pain Study
NCT01364922 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain
NCT00364546 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
NCT01100320 ·Status: COMPLETED ·Phase: PHASE1